Biogen Inc (BIIB)
199.08
-2.91
(-1.44%)
USD |
NASDAQ |
Apr 25, 10:47
Biogen Shares Outstanding: 145.36M for Feb. 12, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 12, 2024 | 145.36M |
December 31, 2023 | 144.90M |
November 07, 2023 | 144.90M |
September 30, 2023 | 144.90M |
July 24, 2023 | 144.82M |
June 30, 2023 | 144.80M |
April 28, 2023 | 144.74M |
April 24, 2023 | 144.74M |
April 20, 2023 | 144.74M |
March 31, 2023 | 144.80M |
February 14, 2023 | 144.49M |
December 31, 2022 | 144.00M |
October 24, 2022 | 144.00M |
September 30, 2022 | 144.00M |
July 19, 2022 | 145.11M |
June 30, 2022 | 145.20M |
May 02, 2022 | 146.45M |
April 21, 2022 | 147.15M |
March 31, 2022 | 147.50M |
February 02, 2022 | 146.96M |
December 31, 2021 | 147.00M |
October 19, 2021 | 146.89M |
September 30, 2021 | 146.90M |
July 21, 2021 | 149.03M |
June 30, 2021 | 149.10M |
Date | Value |
---|---|
April 21, 2021 | 150.55M |
April 09, 2021 | 150.55M |
April 05, 2021 | 150.55M |
March 31, 2021 | 150.60M |
February 02, 2021 | 152.34M |
December 31, 2020 | 152.40M |
October 20, 2020 | 153.88M |
September 30, 2020 | 153.90M |
July 21, 2020 | 158.31M |
June 30, 2020 | 158.30M |
April 22, 2020 | 163.19M |
April 06, 2020 | 166.09M |
March 31, 2020 | 167.30M |
February 04, 2020 | 174.06M |
December 31, 2019 | 174.20M |
October 21, 2019 | 180.44M |
September 30, 2019 | 181.90M |
July 19, 2019 | 184.45M |
June 30, 2019 | 184.80M |
April 22, 2019 | 193.89M |
April 19, 2019 | 193.89M |
March 31, 2019 | 195.20M |
February 01, 2019 | 196.71M |
December 31, 2018 | 197.20M |
October 19, 2018 | 201.48M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
144.00M
Minimum
Sep 30 2022
184.80M
Maximum
Jun 30 2019
153.42M
Average
147.33M
Median
Shares Outstanding Benchmarks
Eli Lilly and Co | 950.77M |
Bristol-Myers Squibb Co | 2.022B |
Gilead Sciences Inc | 1.246B |
AbbVie Inc | 1.766B |
Regeneron Pharmaceuticals Inc | 109.76M |